Indo US Bio-Tech Ltd Q4 FY2023-2024 Results: Summary
Revenue | ₹15.98Cr |
Net Profits | ₹0.52Cr |
Net Profit Margins | 3.25% |
Highlights
Revenue:
Indo US Bio-Tech Ltd’s revenue fell -11.86% since last year same period to ₹15.98Cr in the Q4 2023-2024. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -27.99% fall in its revenue since last 3-months.
Net Profits:
Indo US Bio-Tech Ltd’s net profit fell -81.23% since last year same period to ₹0.52Cr in the Q4 2023-2024. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -85.87% fall in its net profits since last 3-months.
Net Profit Margins:
Indo US Bio-Tech Ltd’s net profit margin fell -78.7% since last year same period to 3.25% in the Q4 2023-2024. On a quarterly growth basis, Indo US Bio-Tech Ltd has generated -80.38% fall in its net profit margins since last 3-months.
